Abstract Atherosclerotic lesions are composed of a complex mixture of cell types that are engorged with lipid and enveloped in extracellular matrix elements. This manifestation probably results from imbalances in the cellular processing of cholesterol-delivering lipoproteins, changes in extracellular matrix deposition, and growth factor elaboration. One receptor class that could modulate these processes is LDL receptorrelated protein/a 2 -macroglobulin receptors (LRP/a 2 -MR). Consequently, the presence of LRP/a 2 -MR was determined on a temporal basis in lesions of distinct morphologies that were developed in cholesterol-fed New Zealand and heterozygous Watanabe heritable hyperlipidemic (WHHL) rabbits. The two strains of rabbits developed similar degrees of hypercholesterolemia in response to 0.5% wt/wt cholesterol in their diet. Lipoprotein-cholesterol distribution was also similar in the two strains. Aortic intimal areas covered by grossly discernible atherosclerotic lesions were extensive and not statistically different between the strains. Despite the similarities in the extent of hypercholesterolemia, lipoprotein distribution, and extent of atherosclerosis, the cellularity of the lesions formed was different in the two groups. Atherosclerotic lesions in A therosclerotic lesions evolve with complex mor-/\ phological characteristics. Consistent features A. A. of lesion progression include the excessive deposition of intracellular cholesterol and extracellular matrix and proliferation of smooth muscle cells (SMCs). While it is likely that many mechanisms may contribute to disease evolution, a recently described cell surface receptor, LDL receptor-related protein (LRP), has properties that could influence many facets of atherogenesis. Originally cloned during a search for complement-type proteins, LRP was determined to have structural features similar to a tandem repeat of the LDL receptor.
cholesterol-fed New Zealand rabbits were uniformly rich in macrophages and deficient in smooth muscle cells, as determined by immunocytochemical staining with the cell-specific monoclonal antibodies RAM-11 and HHF-35. In contrast, atherosclerotic lesions formed in cholesterol-fed heterozygous WHHL rabbits covered a spectrum ranging from macrophagerich lesions to those predominantly composed of disaggregated smooth muscle cells that were embedded in dense layers of extracellular matrix. Immunocytochemical detection of LRP/ nj-MR with the monoclonal antibody 5A6B6 demonstrated that the protein was strongly localized to macrophages of atherosclerotic lesions. The expression of LRP/a 2 -MR mRNA was determined by nuclease protection assay. Relative abundance of LRP/a 2 -MR mRNA in aortic tissue increased modestly during cholesterol feeding. Given the diverse ligand specificity of LRP/a 2 -MR, its presence within atherosclerotic tissue may contribute to the evolution of lesion morphology. pseudomonas exotoxin A, 7 tissue-type plasminogen activator (TPA), 8 urokinase-type plasminogen activator (uPA), 9 TPA/plasminogen activator inhibitor-1 (PAI-1) complexes, 10 uPA/PAI-1 complexes,'i lipoprotein lipase (LPL), 12 and lipoprotein(a). 13 All the interactions of these ligands with LRP/a 2 -MR are inhibited by a 39-kDa protein that copurifies with extracts of LRP/a r MR. 1415 Many studies have characterized atherosclerotic lesions formed by dietary supplementation of cholesterol to New Zealand rabbits. 1617 A uniform observation of atherosclerotic lesions from this strain of rabbits is a predominance of macrophage foam cells. More recently, Atkinson et al 1819 determined the pathological characteristics of atherosclerotic lesions formed in heterozygous Watanabe heritable hyperlipidemic (WHHL) rabbits after cholesterol feeding. The diet prompted a pronounced hypercholesterolemic response in this strain, but the morphology of the resultant vascular lesions was distinct from that of lesions formed in New Zealand rabbits: there was less foam cell formation and more ground matrix in the latter. The availability of these strains permits the characterization of the expres-sion of proteins in specific cell types within atherosclerotic lesions.
The present study defined the presence of LRP/ a 2 -MR in atherosclerotic lesions and determined the major cell types expressing this protein. The study characterized LRP/a 2 -MR on a temporal basis in atherosclerotic lesions formed in aortas of cholesterol-fed New Zealand and heterozygous WHHL rabbits. LRP/ a;-MR mRNA was identified by nuclease protection, and its distribution was delineated by immunocytochemistry. It was demonstrated that LRP/a 2 -MR was predominantly associated with the presence of macrophages. Given the broad spectrum of biological activities of LRP/a 2 -MR, the abundance of this receptor in vascular lesions is likely to impact the atherogenic process.
Methods

Animals/Diets
Homozygous male WHHL rabbits were purchased from Camm's (Wayne, NJ). Specific pathogen-free New Zealand white rabbits of either sex were supplied by Myrtle's Rabbitry Inc (Thompson Station, Tenn). The Fl heterozygous progeny derived from a cross of homozygous WHHL males and New Zealand female rabbits were used. All rabbits were maintained initially on a standard laboratory diet (Ralston Purina). Threemonth-old heterozygous WHHL and New Zealand rabbits of either sex were fed a 0.5% wt/wt cholesterol-enriched diet (Purina Test Diets) ad libitum for 1 or 3 months. All procedures used in this study were approved by the Washington University Animal Studies Committee.
Plasma Measurements
Plasma total cholesterol was measured spectrophotometrically with a commercially available enzymatic kit (Cholesterol C-II; Wako Pure Chemical Industries Ltd). Lipoprotein distribution in plasma was determined by fast protein liquid chromatography (FPLC; LCC-500, Pharmacia) as described previously. 20 Plasma lipoproteins (200 fiL normolipidemic, 100 jtL hypercholesterotemic) were resolved by two Superose 6 columns (HR 10/30) connected in series and eluted with EDTA/NaCl/NaN 3 (1 mmol/L; 0.154 mol/L; 0.02%) at a rate of 0.5 mL/min. Total cholesterol concentrations of fractions were determined by use of Cholesterol C-II kits.
Characterization of Atherosclerotic Lesions
Rabbits were killed with sodium pentobarbital (150 mg/kg) and immediately exsanguinated from the abdominal vena cava. Aortas were dissected free, opened longitudinally, and photographed immediately. Cross sections of the ascending, descending, and thoracic aortas were fixed in 4% wt/vol paraformaldehyde or embedded in ornithine carbamoyltransferase (OCT) and flash frozen in liquid nitrogen. The rest of the aorta was frozen in liquid nitrogen and stored at -80°C until RNA was isolated.
To determine the intimal area covered with grossly discernible atherosclerotic lesions, photographs of the aortas were scanned and quantified with computerized planimetry by use of a Numonic digitizing pad attached to a personal computer running SIGMASCAN software (Jandel Scientific).
Immunohistochemistry was performed with a number of monoclonal antibodies (MAbs). SMCs were identified with HHF-35 (Dako Corp), which reacts with anti-a and anti-y actins of SMCs. 21 Macrophages were identified with RAM-11 (Dako). The RAM-11 antigen has not been identified, and consequently this antibody may not be a pan-macrophage marker. However, at present there is no firm evidence of this effect, and in the absence of any other readily available antibodies to rabbit macrophages, the use of RAM-11 was considered appropriate for defining cell type. LRP was identified by reactivity against MAb 5A6B6 (supplied by Dr D. Strickland 2 ), which reacts with the 85-kd light chain of the protein. ABC kits were purchased from Vector Laboratories, and chromogen, 3-amino,9-ethyl carbazole (AEC), was purchased from Biomeda. In all tissue sections studied for immunoreactivity, control experiments were performed in which chromogen alone was used to determine the completeness of the quenching of endogenous peroxidase, and the primary antibody was excluded to determine the nonspecific reactivity of the secondary antibody. There was no reactivity of the chromogen with the tissue of interest in either of these control situations.
RNA Isolation
RNA was isolated from frozen arterial tissue that was stored at -80°C by the use of RNAzol B (Tel-Test Inc). RNA integrity was examined by methyl mercuric hydroxide denaturation and agarose gel electrophoresis. Only RNA samples with a ratio of absorbances at 260 to 280 nm of > 1.8 that exhibited intact 28S and 18S bands on denaturing agarose gels were used in RNase protection assays.
Construction of Riboprobes
Human LRP/a 2 -MR cDNA was supplied by Dr Joachim Herz. The LRP/a 2 -MR cDNA was digested with Accl-Kpnl, which resulted in a 257 base fragment located between bases 9941 and 10197. The gel-purified fragment was inserted into a pGEM3Z vector (Promega). The identity of the subcloned cDNA was verified by restriction enzyme digests and direct sequencing (Sequenase; USB). The plasmid containing the LRP/a 2 -MR cDNA fragment was linearized with either EcoKL or HindUl, which resulted in anti-sense and sense probes of 297 bp and 285 bp, respectively. 32 P-labeled cRNA probes were synthesized with the Riboprobe system (Promega) and sized with gel electrophoresis and RNA size markers (RNA Century Marker Template set, Ambion). In each experiment, a positive control was performed in which the synthesized anti-sense and sense probes were hybridized and subsequently digested. This hybridization resulted in a protected fragment of 276 bp, which included portions of the pGEM3Z multiple cloning region. The size of the protected fragment for the anti-sense probe against LRP/a 2 -MR mRNA was 257 bp.
Detection of LRP/«,-MR mRNA
LRP/a 2 -MR mRNA was identified with a nuclease protection assay (RPAII, Ambion). Each assay included the following incubations to ensure correct interpretation of results: undigested probe to confirm integrity, digested probe to check on completeness of RNase A/Tl digestion, anti-sense cRNA probe hybridization with sense cRNA for a positive control, and sense and anti-sense cRNA incubations of a variety of aortic samples. Hybridization of the 32 P-labeled cRNA with total arterial RNA was completed by overnight incubation at 45°C. Digestion of nonhybridized 32 P-labeled cRNA by RNase A/Tl was complete after 15 minutes at 30°C. RNA hybridized fragments were resolved on a urea-polyacTylamide gel and subjected to autoradiography. Fragments were sized by comparison with ^-labeled RNA size markers.
Western Blot Analysis
A grossly atherosclerotic aorta from a New Zealand rabbit fed a cholesterol-enriched diet for 12 weeks was pulverized with a stainless-steel pestle and mortar at the temperature of liquid nitrogen. The crushed vessel was extracted in water containing 1% wt/vol SDS. A 20-jig protein aliquot of the aortic extract was electrophoresed on a 10% wt/vol polyacrylamide gel in a mini-Protean system (Bio-Rad). Protein was transferred to poh/vinylidene fluoride membranes (Micro Separations Industries). After overnight incubation with shaking in 5% wt/vol nonfat dry milk in phosphate-buffered saline at 37°C, the membrane was incubated with 5A6B6 (1:100 dilution of supplied ascites fluid) for 30 minutes at 37°C. The blot was treated in accordance with the instructions supplied by Vector Laboratories, and reactivity was observed after developing the blot in AEC.
Statistical Analyses
Student's t test was used for statistical comparison of plasma cholesterol concentrations. Comparison of the extent of atherosclerosis did not conform to the constraints of Student's t test, so this analysis was carried out with a Wilcoxon rank-sum test. Statistical analysis was performed with SIGMASTAT for Windows (Jandel Scientific). For both tests, a probability value of <.O5 was considered to be indicative of a statistically significant difference. Data are expressed as mean±SEM.
Results
Both New Zealand and heterozygous WHHL rabbits were placed on a 0.5% wt/wt cholesterol-enriched diet at approximately 3 months of age. The modified diet was well accepted by both strains, and weight gain was normal and similar. The onset of hypercholesterolemia prompted by the cholesterol-enriched diet was slightly more rapid for the heterozygous WHHL rabbits. However, by week 8 of the modified diet, there was an insignificant difference in the plasma cholesterol concentrations in rabbits of the two strains (Fig 1) . Plasma was fractionated by size exclusion FPLC to determine the distribution of cholesterol among lipoprotein classes. Lipoprotein cholesterol distributions were similar in the two strains on normal diet, with the major portion of the cholesterol being carried by HDL (Fig 2A  and 2C ). Lipoprotein distributions of cholesterol were also similar in the two strains after cholesterol feeding. A major portion of cholesterol was present in large LDL fractions, with most of the remainder residing in the exclusion volume that would contain chylomicrons, chylomicron remnants, and hepatically derived VLDL (Fig  2B and 2D) . present at this time was generally located in the aortic arch and branch points of the intercostal and renal arteries. Atherosclerotic lesions were extensive in both groups at 12 weeks (Fig 3) . There was no statistically significant difference between the groups in the extent of atherosclerosis determined in either the thoracic or abdominal region. To determine whether LRP/a 2 -MR mRNA was present in vascular tissue and whether expression was influenced by the atherogenic process, a nuclease protection assay was established and validated. The LRP/ a 2 -MR cDNA was subcloned to permit identification of a protected fragment of 257 bp after formation of P-labeled cRNA-mRNA hybrids and digestion with RNase A/Tl. Total RNA was extracted from four arterial tissue samples from each gioup, and 50 /ig of total RNA was hybridized with the "P-labeled antisense cRNA probe. An example of the relative abundance of LRP/a r MR mRNA is shown in Fig 4, trating results of experiments in which the protected fragment was demonstrated with total RNA from aortic tissue. There appeared to be an increase in the relative abundance of LRP/a 2 -MR mRNA in the cholesterol-fed groups versus controls fed a normal laboratory diet.
To determine the localization of LRP/a 2 -MR protein, immunocytochemistry was performed with the MAb 5A6B6. This antibody was raised against the light chain (85 kd) of human LRP/a 2 -MR; it has been shown previously to be specific for this protein. 2 To determine whether 5A6B6 exhibited equivalent specificity in rabbit tissue, a sample from an atherosclerotic aorta was homogenized, and the homogenate was subjected to Western blotting. Fig 5 illustrates a Western blot against protein extracted from an atherosclerotic rabbit aorta and shows the monospecificity of MAb 5A6B6 for a band that is of the expected migration for the 85-kd LRP/a 2 -MR fragment.
After the specificity of 5A6B6 was confirmed, the antibody was used in immunocytochemical studies to determine whether LRP/a 2 -MR was present in atherosclerotic lesions and to identify the cell type that possesses this protein. RAM-11, 24 which consistently stained virtually all the cells present in the intimal area, an observation compatible with this area being engorged with foam cells. At this early stage in the evolution of atherosclerosis, the regions immunostained with MAb 5A6B6 (Fig 6B and  6D ) and RAM-11 were similar. Fig 7A through 7C shows results of immunostaining with HHF-35, RAM-11, and 5A6B6 of atherosclerotic tissue removed from a New Zealand rabbit fed a cholesterol-enriched diet for 12 weeks. HHF-35 immunostaining for SMCs was minimal in the atherosclerotic intima. As expected, the media reacted uniformly with HHF-35. RAM-11 immunostained all but the acellular core region. Some modest and diffuse immunostaining with 5A6B6 occurred throughout the SMC-containing media, but the most intense immunostaining for LRP/ a 2 -MR was in regions that were identified as macrophage rich on the basis of RAM-11 immunostaining. Fig 7D through 7F shows results of immunostaining of atherosclerotic lesions from a heterozygous WHHL rabbit fed a cholesterol-enriched diet for 12 weeks. The lesion in Fig 7D was immunostained with HHF-35 , which uniformly interacted with the media. There was a band of HHF-35 immunostaining in the marginal region of lesions; this appeared to be relatively acellular and fibrous. Immunostaining for macrophages with RAM-11 was more sparse (Fig 7E) than routinely observed in atherosclerotic lesions from cholesterol-fed New Zealand rabbits. In this example, there was a clustering of macrophage staining in the core region and sporadic staining throughout the remaining atherosclerotic lesion. Tissue in Fig 7F was immunostained with 5A6B6 to determine whether the presence of LRP/a 2 -MR corresponded to a specific cell type. 5A6B6 also failed to prominently immunostain the media of this section. The general pattern of immunostaining within the atherosclerotic lesion of the intima more closely matched that of RAM-11 than of HHF-35. Therefore, in both rabbit strains studied at early and later stages of development, LRP/a 2 -MR was a prominent feature of atherosclerotic lesions. Furthermore, the distribution of LRP/a 2 -MR expression was most consistently related to the macrophage content of lesions.
Discussion
The present study has determined the presence of LRP/a 2 -MR in diet-induced atherosclerotic tissue from New Zealand and heterozygous WHHL rabbits at early and late stages of lesion evolution. The cellularity of atherosclerotic lesions and the spatial expression of LRP/a 2 -MR was identified by MAbs in immunocytochemical studies. Contrasting evolving atherosclerotic lesions of diverse morphologies showed the distribution of LRP/a 2 -MR to be predominantly localized to macrophages within diseased intimal regions of arteries at all stages of development.
Atherosclerotic lesions from cholesterol-fed heterozygous WHHL rabbits have been demonstrated previously to have very different pathological characteristics compared with those from cholesterol-fed New Zealand rabbits. 18 ' 19 Consequently, the rationale for using these two strains was to study the expression of LRP/a 2 -MR in atherosclerotic lesions with differing cellular characteristics. The response to the dietary perturbation was similar in the two strains, with comparable cholesterol concentrations and lipoprotein-cholesterol distributions among rabbits on normal and among those on cholesterol-supplemented diets. Also, the extent of aortic atherosclerosis produced was similar in the two strains. Cholesterol feeding of New Zealand rabbits produced atherosclerotic lesions in which macrophages were the predominant cell type at both early and late stages of the disease. Selected advanced atherosclerotic lesions of cholesterol-fed heterozygous WHHL rabbits were similar to those described by Atkinson et al, 1819 with a prominent SMC component and extensive extraceUular matrix deposition. However, early lesions from cholesterol-fed heterozygous WHHL rabbits were composed mainly of macrophages. Also, at later stages, predominantly macrophage-rich atherosclerotic lesions were observed frequently, in addition to the SMC-containing lesions shown in Fig 7. Thus, while cholesterol-fed heterozygous WHHL rabbits may develop lesions with cellular characteristics distinct from those in New Zealand rabbits, there is not an absolute distinction between the pathological characteristics of atherosclerosis in these two strains.
Recently, Luoma et al 23 described the distribution of LRP/a 2 -MR in human atherosclerotic lesions. As in the present study, LRP/a 2 -MR was detected in macrophage-rich regions, but contrary to our findings, pronounced immunostaining was also observed in SMCs. Although SMC-associated LRP/a 2 -MR was not conspicuous in the present study, the diffuse immunostaining throughout the medial layers of arteries indicated protein expression, albeit much less prominently than in macrophages. Furthermore, the ready detection of LRP/a 2 -MR mRNA in aortas from normolipidemic rabbits, which contain primarily a medial layer, is consistent with the presence of the receptor in SMCs. Thus, the relative abundance of LRP/a 2 -MR within macrophages and SMCs of atherosclerotic lesions may rely on uncharacterized control mechanisms.
LRP/a 2 -MR has been proposed as a monocyte differentiation marker. 26 Therefore, although the distribution of LRP/a 2 -MR has not been described in experimental atherosclerosis, its presence within monocyte-derived tissue macrophages was not unexpected. Whereas monocytes express LRP/a 2 -MR, the milieu within atherosclerotic lesions may provide local regulation of LRP/a 2 -MR expression on macrophages. Cellular expression of LRP/a 2 -MR is not modulated by cholesterol engorgement of macrophages, as there are no sterol regulatory elements in the gene promoter region despite the fact that LRP/a 2 -MR is a member of the LDL receptor family. 27 However, nonsterol regulation of the receptor may be an important mechanism in macrophages of evolving atherosclerotic lesions. For example, macrophage colony stimulating factor and phorbol ester-stimulated monocyte differentiation increases LRP/a 2 -MR mRNA expression in macrophages. 28 - 29 Receptor expression is also stimulated by insulin in adipocytes, 30 although it is not known whether a similar mechanism exists in cells of atherosclerotic lesions. Conversely, macrophage LRP/a 2 -MR is negatively regulated by interferon-y. 31 35 The presence of apolipoprotein EM-38 and ljpoprotein lipase 39 within atherosclerotic lesions would permit the generation of these atherogenic LRP/a 2 -MR ligands.
LRP/a 2 -MR may modulate extracellular matrix deposition and cellular proliferation directly via ligand interaction or indirectly through recognition of activated a 2 -macroglobulin. Direct receptor mechanisms may be mediated by interaction of proteins modulating proteorysis. 810 Indirect interactions of LRP/a 2 -MR are mediated through recognition of activated ^-macroglobulin, which interacts with all four classes of proteases to enable LRP/a 2 -MR to provide a clearance mechanism for these enzymes. 40 Activated a 2 -macroglobulin-LRP/o 2 -MR-mediated clearance of proteases would limit local proteolysis and promote extracellular matrix deposition. LRP/a 2 -MR also interacts with cytokines to modulate cell growth. Activated a 2 -macroglobulin interacts with a number of cytokines, including platelet-derived growth factor (PDGF), 41 transforming growth factor-^ (TGF-/3), 42 -43 basic fibroblast growth factor, 44 interleukin-10, 45 and tumor necrosis factor-a. 46 The interactions of activated a 2 -macroglobulin with TGF-/9 47 and PDGF 48 may be particularly important in influencing SMC growth and proliferation.
In summary, LRP/a 2 -MR is present in experimental atherosclerotic lesions produced by dietary cholesterol supplementation in both New Zealand and heterozygous WHHL rabbits. Macrophages were the major cell type expressing LRP/a 2 -MR at both early and late stages of the disease in both strains of rabbits. Further work will be needed to define whether macrophage phenotype is associated with regulation of LRP/a 2 -MR expression. Given the abundance of LRP/a r MR in atherosclerotic lesions and its diverse ligand specificity, its presence is likely to contribute to the atherogenic process. Development of a means to regulate LRP/ «2-MR will provide insight into the importance of this receptor class in the atherogenic process.
